Guoqing Cao
Lilly Research Laboratories
359 Merrill Street
Indianapolis
Indiana
USA. ;
Name/email consistency: high
- Glycerolipid acyltransferases in triglyceride metabolism and energy homeostasis-potential as drug targets. Cao, G., Konrad, R.J., Li, S.D., Hammond, C. Endocr. Metab. Immune. Disord. Drug. Targets (2012)
- Further LDL cholesterol lowering through targeting PCSK9 for coronary artery disease. Cao, G., Qian, Y.W., Kowala, M.C., Konrad, R.J. Endocr. Metab. Immune. Disord. Drug. Targets (2008)
- Liver X receptor-mediated gene regulation and cholesterol homeostasis in brain: relevance to Alzheimer's disease therapeutics. Cao, G., Bales, K.R., DeMattos, R.B., Paul, S.M. Curr. Alzheimer. Res (2007)
- Liver X receptors as potential therapeutic targets for multiple diseases. Cao, G., Liang, Y., Jiang, X.C., Eacho, P.I. Drug News Perspect. (2004)
- Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis. Cao, G., Liang, Y., Broderick, C.L., Oldham, B.A., Beyer, T.P., Schmidt, R.J., Zhang, Y., Stayrook, K.R., Suen, C., Otto, K.A., Miller, A.R., Dai, J., Foxworthy, P., Gao, H., Ryan, T.P., Jiang, X.C., Burris, T.P., Eacho, P.I., Etgen, G.J. J. Biol. Chem. (2003)